• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

DYAX:US

9.0400 USD 0.0500 0.55%

As of 20:10:00 ET on 07/24/2014.

Snapshot for Dyax Corp (DYAX)

Open: 9.1300 Day's Range: 8.9000 - 9.2100 Volume: 792,421
Previous Close: 9.0900 52wk Range: 3.6800 - 10.9900 1-Yr Rtn: +118.89%

Stock Chart for DYAX

No chart data available.
  • DYAX:US 9.0400
  • 1D
  • 1M
  • 1Y
9.0900
Interactive DYAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DYAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2100
Est. EPS (USD) (12/2014) -0.1970
Est. PEG Ratio -
Market Cap (M USD) 1,227.64
Shares Outstanding (M) 135.80
30 Day Average Volume 1,142,125
Price/Book (mrq) 11.8867
Price/Sale (ttm) 18.5616
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DYAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DYAX

Dyax Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of antibodies, small proteins and peptides as therapeutic products for unmet medical needs, particularly in the areas of inflammation and oncology. The Company currently has two recombinant proteins, DX-88 and DX-890 in phase II clinical trials.

Gustav A ChristensenPresident/CEOGeorge V MigauskyExec VP/CFO
Burt A AdelmanExec VP/Chief Medical OfcrAndrew AsheExec VP/General Counsel
More Company Profile & Key Executives for DYAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil